Name: Tuam Tshoj Retatrutide CAS 2381089-83-2 Manufacturers, lwm tus neeg thiab Hoobkas - Custom Service - Sunite
Brand: Sunite
SKU: 311052434

Shanghai Sunite Biotechnology Co., Ltd. yog ib qho ntawm cov tuam txhab ua lag luam thiab cov neeg muag khoom ntawm rettrutide cas 2381089-83-2 hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo retutide cas 2381089-83-2 los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.

Khoom npe	CAS: 2381089-83-2; Retatrutide CAS TSIS: 2381089-83-2
Ib ntus
Peb tsab ntawv ib ntus	Tyr-{Aib}-Gln-Gly-Thr-Ph-Thr-Ser-Asp-Tyr-Ser-Ile-{ -Methyl{13}}Leu}-Leu-Asp-Lys-{diacid-C20-ga mma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-P nws-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly{{37} }Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Peptide purity (HPLC, %)	95%/98%
Cov mis mos molecular	C221H342N46O68
Molecular Luj (Da)	4731.33

Product Basic Information Table

Khoom Lub Npe Lus Askiv	Product Abbreviation / Alias	Function Tags (comma-sib cais)	Amino Acid Tag Nrho Lub Npe Sequence	Molecular Formula	Qhov hnyav Molecular (Da)	Qhov Nruab Nrab Molecular Luj (Da)	Terminal Hloov kho - N-terminus	Terminal Hloov kho - C-terminus	Qhov ntev (aa)
Retatrutide	#Retatrutide; CAS 2381089-83-2; LY3437943; GGG Tri-agonist; Triple G	GIP/GLP-1/Glucagon triple agonist, Muaj zog yuag- poob peptide, Ntev- ua lipidated, Kev siv zog siv zog, Kev tshawb fawb kev rog rog, ntau lub hom phiaj GPCR, Hom 2 mob ntshav qab zib, Cardiometabolic	Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile- -{MeLeu{{11}{3}}Leu -Glu-eicosanedioic acid sab chain)-Gln-Glu-Ph-Val-Gln-Trp-Leu-Leu-Lys-Asn-G ly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-amide	C₂₂₁H₃₄₂N₄₆O₆₈	4728.5	4731.33	Dawb amine, unmodified	C-terminal amidation (-NH₂)	39

Physicochemical Solubility & Cia Parameters

Khoom Code	Qhov tshwm sim	Pom zoo Dissolution Protocol (los ntawm hnyav)	Solubility Reference	Tsis pom zoo Solvents	Ntev - Lub Sij Hawm Cia Cov Cai	Luv luv -Lub Sijhawm Cia Cia	Kua Stability	Khoom hmoov ruaj khov	Muaj feem xyuam pH Range
PEB-RET001	Dawb kom tawm -dawb lyophilized hmoov	Dilute acetic acid, Sterile dej rau txhaj, PBS (pH7.4); Lipid saw coj siab hydrophobicity, yaj hauv dilute acetic acid ua ntej ces dilute nrog tsis	Ntau dua lossis sib npaug li 5 mg / mL (0.1% aqueous acetic acid)	Cov dej ntshiab (tsawg solubility), alkanes, roj av ether organic solvents	-20 degree, kaw thiab lub teeb- pov thawj, aliquot kom tsis txhob rov khov-thaw	2 ~ 8 degree, siv nyob rau hauv 1 lub hlis, npaj tshiab thiab tsis muaj menyuam - lim ua ntej siv	ruaj khov rau 48 h ntawm 4 degree	ruaj khov rau 3 xyoos ntawm -20 degree	4.0~8.0

Functional Description

Khoom Code	Frontend Short Summary (rau cov npe tshawb nrhiav)	Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg	Cov Cheeb Tsam Tshawb Fawb (comma- cais)	Hom phiaj / Receptor
PEB-RET001	Retatrutide yog GIP- caj qaum engineered triple agonist co- ua kom GIPR / GLP-1R / GCGR, nrog kev poob phaus zoo dua, tswj glycemic thiab kev siv hluav taws xob txhawb nqa cov txiaj ntsig, ntsuas tri-target tool peptide hauv kev tshawb fawb metabolic	Retatrutide (LY3437943) yog 39-amino-acid synthetic peptide uas tau tsim kho hnyav rau ntawm cov pob txha GIP ib txwm muaj, sawv cev rau thawj-hauv-chav GIP/GLP-1/Glucagon triple receptor agonist. Kev hloov kho cov qauv tseem ceeb: Aib ntawm txoj hauj lwm 2 thiab -MeLeu ntawm txoj hauj lwm 13 confer DPP-4 tsis kam; Lys17 sab saw yog sib txuas rau C20 fatty diacid ntawm -glutamyl linker rau albumin-binding mediated ntev ib nrab-lub neej; C-terminal amidation txhim khu kev ruaj ntseg. Nws koom nrog peb receptors nrog sib npaug potency: lub zog siab tshaj plaws ntawm GIPR (~ 8.9-fold vs haiv neeg GIP), kev ua kom nruab nrab ntawm GLP-1R, thiab kev ua kom qis GCGR. Synergistic poob phaus & glycemic cuam tshuam tau ua tiav los ntawm kev noj qab haus huv hauv nruab nrab, ncua kev ua pa ntawm plab, txhim kho insulin tso tawm, nce siab oxidation ntawm lub siab thiab kev siv zog siab - xa cov kev kho mob zoo dua qhov hnyav dua vs ib leeg- thiab ob lub hom phiaj agonists. Siv dav hauv kev rog, hom 2 mob ntshav qab zib, NAFLD / NASH, metabolic syndrome, kab mob cardiometabolic thiab ntau lub hom phiaj GPCR peptide kev tshawb fawb tshuaj	Metabolic endocrinology, Kev rog rog -kev tshawb fawb poob, hom 2 mob ntshav qab zib hom, kev tshawb fawb NAFLD/NASH, Cardiometabolism, GPCR pharmacology, Ntev- ua peptide formulation, Zog metabolism kev tswj	GIP Receptor (GIPR); GLP-1 Receptor (GLP-1R); Glucagon Receptor (GCGR) - tag nrho Class B GPCRs

Cov Ntaub Ntawv Tswj Xyuas Zoo

Khoom Code	Purity Detection Method	Molecular Weight Verification Method	Quality Control Indicators	Impurity Control Standards
PEB-RET001	HPLC High Performance Liquid Chromatography	ESI-HRMS High Resolution Mass Spectrometry	Purity, dej ntsiab lus, Acetate, Hnyav hlau, Residual hnyav, Lipid sab saw conjugation tus nqi	Ib qho impurity Tsawg dua lossis sib npaug li 2%, Tag nrho cov impurities Tsawg dua lossis sib npaug li 5%

SKU Specifications & Inventory Table

SKU Unique Code	Yam khoom Code	HPLC Purity	Ntim Specification	Lub Sijhawm Ua Haujlwm Ntau Lawm	Customizable	Optional Custom Modifications	Cov ntaub ntawv suav nrog
PEP-RET001-98-1	PEB-RET001	Ntau dua lossis sib npaug li 98%	1mg ib	7-14 hnub ua haujlwm	Yog lawm	Isotope labeling, Fluorescent labeling, Lipid chain length variants, Terminal modification	CoA, HPLC spectrum, MS huab hwm coj spectrum, Lipid hloov kho cov ntaub ntawv pov thawj
PEB-RET001-98-5	PEB-RET001	Ntau dua lossis sib npaug li 98%	5mg ib	7-14 hnub ua haujlwm	Yog lawm	Isotope labeling, Fluorescent labeling, Lipid chain length variants, Terminal modification	CoA, HPLC spectrum, MS huab hwm coj spectrum, Lipid hloov kho cov ntaub ntawv pov thawj
PEP-RET001-95-1	PEB-RET001	Ntau dua lossis sib npaug li 95%	1mg ib	7-14 hnub ua haujlwm	Yog lawm	Isotope labeling, Fluorescent labeling, Lipid chain length variants, Terminal modification	CoA, HPLC spectrum, MS huab hwm coj spectrum, Lipid hloov kho cov ntaub ntawv pov thawj